Skip to main content
Fig. 3 | Respiratory Research

Fig. 3

From: Corticosteroid plus β2-agonist in a single inhaler as reliever therapy in intermittent and mild asthma: a proof-of-concept systematic review and meta-analysis

Fig. 3

Effects of the as-needed ICS/FABA, daily ICS, and as-needed FABA regimens on severe exacerbations. a ICS/FABA vs FABA regimen; b ICS/FABA vs ICS regimen; c Risk ratio across three regimens. ICS, inhaled corticosteroids; FABA, fast-onset-acting β2-agonist; ICS/FABA, inhaled corticosteroids/fast-onset-acting β2-agonist

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us